You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

AZO GANTANOL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Azo Gantanol, and what generic alternatives are available?

Azo Gantanol is a drug marketed by Roche and is included in one NDA.

The generic ingredient in AZO GANTANOL is phenazopyridine hydrochloride; sulfamethoxazole. There are eight drug master file entries for this compound. Additional details are available on the phenazopyridine hydrochloride; sulfamethoxazole profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZO GANTANOL?
  • What are the global sales for AZO GANTANOL?
  • What is Average Wholesale Price for AZO GANTANOL?
Summary for AZO GANTANOL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 119
DailyMed Link:AZO GANTANOL at DailyMed
Drug patent expirations by year for AZO GANTANOL

US Patents and Regulatory Information for AZO GANTANOL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Roche AZO GANTANOL phenazopyridine hydrochloride; sulfamethoxazole TABLET;ORAL 013294-001 Sep 10, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.